Pharmacyclics

The 10 drugs that CMS might wrangle into negotiations
The 10 drugs that CMS might wrangle into negotiations
Beckers Hospital Review
CMS
Medicare
drug pricing
Bristol Myers Squibb
Janssen
Merck
Pfizer
Amgen
Boehringer Ingelheim
Pharmacyclics
AstraZeneca
Astellas
GSK
Flag link:
AbbVie sues BeiGene over brand-new Imbruvica patent as blood cancer rivalry heats up
AbbVie sues BeiGene over brand-new Imbruvica patent as blood cancer rivalry heats up
Fierce Pharma
AbbVie
Pharmacyclics
BeiGene
Brukinsa
patents
Imbruvica
blood cancer
Flag link:
An AbbVie clinical vet heading early oncology jumps ship to build his own team at NK cell-focused biotech
An AbbVie clinical vet heading early oncology jumps ship to build his own team at NK cell-focused biotech
Endpoints
Thorsten Graef
Pharmacyclics
AbbVie
oncology
Acepodia
NK cells
Flag link:
4 US pharma execs make Forbes 400 list
4 US pharma execs make Forbes 400 list
BioPharma Dive
Patrick Soon-Shiong
NantWorks
Phillip Frost
OPKO Health
Randal Kirk
Intrexon
Robert Duggan
Pharmacyclics
Flag link:
Why AbbVie Inc Spent $21 Billion to Buy Pharmacyclics
Why AbbVie Inc Spent $21 Billion to Buy Pharmacyclics
Motley Fool
AbbVie
Pharmacyclics
M&A
Flag link:
Did AbbVie Blow $21 Billion Buying Pharmacyclics?
Did AbbVie Blow $21 Billion Buying Pharmacyclics?
Motley Fool
AbbVie
Pharmacyclics
M&A
Flag link:
In pharma M&A, 2015 trumps red-hot 2014 so far, report says
In pharma M&A, 2015 trumps red-hot 2014 so far, report says
Fierce Pharma
M&A
Teva Pharmaceutical
Allergan
AbbVie
Pharmacyclics
Perrigo
Mylan Labs
Flag link:
2015’s Top 6 Big Pharma Headlines Thus Far
2015’s Top 6 Big Pharma Headlines Thus Far
Motley Fool
Pfizer
M&A
Hospira
AbbVie
Pharmacyclics
PCSK9 inhibitors
Amgen
Sanofi
Regeneron
Express Scripts
Bristol-Myers Squibb
Opdivo
Flag link:
Ex-Pharmacyclics team raises $33.5M for checkpoint drug
Ex-Pharmacyclics team raises $33.5M for checkpoint drug
Fierce Biotech
Pharmacyclics
Corvus Pharmaceuticals
Flag link:
For Pharma, the Hollywood Model of Buying Pipeline Hits is not a Panacea
For Pharma, the Hollywood Model of Buying Pipeline Hits is not a Panacea
WSJ Pharmalot
JNJ
Gilead Sciences
hepatitis C
Pharmacyclics
Flag link:
Bad news for AbbVie: Humira copies expected to rack up biggest biosim sales
Bad news for AbbVie: Humira copies expected to rack up biggest biosim sales
Fierce Pharma
AbbVie
Humira
biosimilars
Pharmacyclics
Flag link:
AbbVie Completes Acquisition of Pharmacyclics
AbbVie Completes Acquisition of Pharmacyclics
Yahoo
AbbVie
Pharmacyclics
M&A
Flag link:
The Most Loved Biotechs of Big Hedge Funds
The Most Loved Biotechs of Big Hedge Funds
24/7 Wall St
biotech
Pharmacyclics
Gilead Sciences
Regeneron
Celgene
Amgen
Flag link:
Abbvie specifies breakdown of $21 billion Pharmacyclics deal
Abbvie specifies breakdown of $21 billion Pharmacyclics deal
Yahoo/AP
AbbVie
Pharmacyclics
M&A
Flag link:
AbbVie Extends Exchange Offer to Acquire Pharmacyclics, Inc.
AbbVie Extends Exchange Offer to Acquire Pharmacyclics, Inc.
Yahoo
AbbVie
Pharmacyclics
M&A
Flag link:
Pharmacyclics-AbbVie Merger Has Many Moving Parts
Pharmacyclics-AbbVie Merger Has Many Moving Parts
Seeking Alpha
AbbVie
Pharmacyclics
M&A
Flag link:
AbbVie Again Extends Exchange Offer to Acquire Pharmacyclics, Inc.
AbbVie Again Extends Exchange Offer to Acquire Pharmacyclics, Inc.
Marketwatch
AbbVie
Pharmacyclics
M&A
Flag link:
Pharmacyclics tops 1Q profit forecasts
Pharmacyclics tops 1Q profit forecasts
Yahoo/AP
Pharmacyclics
earnings
Flag link:
Why didn't J&J buy Imbruvica partner Pharmacyclics? It wants hot drugs cheap, CEO says
Why didn't J&J buy Imbruvica partner Pharmacyclics? It wants hot drugs cheap, CEO says
Fierce Pharma
JNJ
M&A
Pharmacyclics
AbbVie
Alex Gorsky
Flag link:
Is AbbVie Inc. Stock About to Crash?
Is AbbVie Inc. Stock About to Crash?
Motley Fool
AbbVie
Pharmacyclics
Flag link:

Pages